−0.062 EUR
−1.55 M EUR
5.02 M EUR
22.45 M
About SENZAGEN AB
Sector
Industry
CEO
Peter Nählstedt
Website
Headquarters
Lund
Founded
2010
ISIN
SE0010219626
FIGI
BBG00HVT8T57
SenzaGen AB engages in the development of in vitro test methods for prediction of chemical and protein sensitizers. It offers services for assessment of sensitizers for industry and regulatory purposes, using its proprietary technology called GARD (Genomic Allergen Rapid Detection). It serves clients in cosmetic, chemical, pharmaceutical, and food industries. The company was founded by Malin Marie Lindstedt and Carl Arne Krister Borrebaeck on August 18, 2010 and is headquartered in Lund, Sweden.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange SENZAGEN AB stocks are traded under the ticker 26S.
We've gathered analysts' opinions on SENZAGEN AB future price: according to them, 26S price has a max estimate of 1.19 EUR and a min estimate of 1.19 EUR. Watch 26S chart and read a more detailed SENZAGEN AB stock forecast: see what analysts think of SENZAGEN AB and suggest that you do with its stocks.
Yes, you can track SENZAGEN AB financials in yearly and quarterly reports right on TradingView.
SENZAGEN AB revenue for the last quarter amounts to 1.26 M EUR, despite the estimated figure of 1.46 M EUR. In the next quarter, revenue is expected to reach 1.42 M EUR.
26S net income for the last quarter is −375.95 K EUR, while the quarter before that showed −407.56 K EUR of net income which accounts for 7.76% change. Track more SENZAGEN AB financial stats to get the full picture.
No, 26S doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 27, 2025, the company has 34 employees. See our rating of the largest employees — is SENZAGEN AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SENZAGEN AB EBITDA is −232.54 K EUR, and current EBITDA margin is −6.91%. See more stats in SENZAGEN AB financial statements.
Like other stocks, 26S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SENZAGEN AB stock right from TradingView charts — choose your broker and connect to your account.